Cargando…

Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases

Background: In women with rheumatic diseases (RDs) menstruation-related disorders have never been investigated. The aim of this study was to evaluate gynecological symptoms/disorders in fertile age women with RDs. Materials and methods: All patients (n = 200) filled up a self-administered questionna...

Descripción completa

Detalles Bibliográficos
Autores principales: Orlandi, Martina, Vannuccini, Silvia, El Aoufy, Khadija, Melis, Maria Ramona, Lepri, Gemma, Sambataro, Gianluca, Bellando-Randone, Silvia, Guiducci, Serena, Cerinic, Marco Matucci, Petraglia, Felice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854987/
https://www.ncbi.nlm.nih.gov/pubmed/35185567
http://dx.doi.org/10.3389/fphar.2022.807880
_version_ 1784653555812007936
author Orlandi, Martina
Vannuccini, Silvia
El Aoufy, Khadija
Melis, Maria Ramona
Lepri, Gemma
Sambataro, Gianluca
Bellando-Randone, Silvia
Guiducci, Serena
Cerinic, Marco Matucci
Petraglia, Felice
author_facet Orlandi, Martina
Vannuccini, Silvia
El Aoufy, Khadija
Melis, Maria Ramona
Lepri, Gemma
Sambataro, Gianluca
Bellando-Randone, Silvia
Guiducci, Serena
Cerinic, Marco Matucci
Petraglia, Felice
author_sort Orlandi, Martina
collection PubMed
description Background: In women with rheumatic diseases (RDs) menstruation-related disorders have never been investigated. The aim of this study was to evaluate gynecological symptoms/disorders in fertile age women with RDs. Materials and methods: All patients (n = 200) filled up a self-administered questionnaire on their gynecological history, menstrual cycle pattern, menstrual-related symptoms, and quality of life (QoL). The RD group was then compared to a control group of 305 age-matched fertile age women. Results: Among patients with RDs, 58% had arthritis, 40% connective tissue diseases (CTDs), and 1.5% systemic vasculitis. No differences were observed between CTDs and arthritis, except for a family history of HMB which was more common among women with CTDs (p < .01). When compared to controls, women with RDs reported more frequent heavy menstrual bleeding (HMB) during adolescence (51.7 and 25.4%, respectively; p = .0001) and adult life (37.7 and 25.9%, respectively; p = .0065). Also, dysmenorrhea in adolescence was significantly more common among cases (55.6 and 45.4%, respectively; p = .0338). Gynecological pain (dysmenorrhea, non-menstrual pelvic pain, dyspareunia, dysuria, and dyschezia) in patients with RDs was more frequent than in controls (p = .0001, .0001, .0001, .0001, .0002, respectively). Considering women who reported moderate and severe symptoms in RDs, dysmenorrhea and dyspareunia remain significantly more frequent in women with RDs than in controls (p = .0001; p = .0022; respectively). QoL scores were significantly reduced in women with RDs, either in physical (p = .0001) and mental domains (p = .0014) of short-form 12. Conclusion: Women affected by RDs frequently presented menstruation-related disorders; thus, female patients with RDs should be questioned about gynecological symptoms and referred to the gynecologist for an accurate evaluation.
format Online
Article
Text
id pubmed-8854987
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88549872022-02-19 Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases Orlandi, Martina Vannuccini, Silvia El Aoufy, Khadija Melis, Maria Ramona Lepri, Gemma Sambataro, Gianluca Bellando-Randone, Silvia Guiducci, Serena Cerinic, Marco Matucci Petraglia, Felice Front Pharmacol Pharmacology Background: In women with rheumatic diseases (RDs) menstruation-related disorders have never been investigated. The aim of this study was to evaluate gynecological symptoms/disorders in fertile age women with RDs. Materials and methods: All patients (n = 200) filled up a self-administered questionnaire on their gynecological history, menstrual cycle pattern, menstrual-related symptoms, and quality of life (QoL). The RD group was then compared to a control group of 305 age-matched fertile age women. Results: Among patients with RDs, 58% had arthritis, 40% connective tissue diseases (CTDs), and 1.5% systemic vasculitis. No differences were observed between CTDs and arthritis, except for a family history of HMB which was more common among women with CTDs (p < .01). When compared to controls, women with RDs reported more frequent heavy menstrual bleeding (HMB) during adolescence (51.7 and 25.4%, respectively; p = .0001) and adult life (37.7 and 25.9%, respectively; p = .0065). Also, dysmenorrhea in adolescence was significantly more common among cases (55.6 and 45.4%, respectively; p = .0338). Gynecological pain (dysmenorrhea, non-menstrual pelvic pain, dyspareunia, dysuria, and dyschezia) in patients with RDs was more frequent than in controls (p = .0001, .0001, .0001, .0001, .0002, respectively). Considering women who reported moderate and severe symptoms in RDs, dysmenorrhea and dyspareunia remain significantly more frequent in women with RDs than in controls (p = .0001; p = .0022; respectively). QoL scores were significantly reduced in women with RDs, either in physical (p = .0001) and mental domains (p = .0014) of short-form 12. Conclusion: Women affected by RDs frequently presented menstruation-related disorders; thus, female patients with RDs should be questioned about gynecological symptoms and referred to the gynecologist for an accurate evaluation. Frontiers Media S.A. 2022-02-04 /pmc/articles/PMC8854987/ /pubmed/35185567 http://dx.doi.org/10.3389/fphar.2022.807880 Text en Copyright © 2022 Orlandi, Vannuccini, El Aoufy, Melis, Lepri, Sambataro, Bellando-Randone, Guiducci, Cerinic and Petraglia. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Orlandi, Martina
Vannuccini, Silvia
El Aoufy, Khadija
Melis, Maria Ramona
Lepri, Gemma
Sambataro, Gianluca
Bellando-Randone, Silvia
Guiducci, Serena
Cerinic, Marco Matucci
Petraglia, Felice
Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases
title Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases
title_full Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases
title_fullStr Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases
title_full_unstemmed Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases
title_short Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases
title_sort menstruation-related disorders—dysmenorrhea and heavy bleeding—as significant epiphenomena in women with rheumatic diseases
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854987/
https://www.ncbi.nlm.nih.gov/pubmed/35185567
http://dx.doi.org/10.3389/fphar.2022.807880
work_keys_str_mv AT orlandimartina menstruationrelateddisordersdysmenorrheaandheavybleedingassignificantepiphenomenainwomenwithrheumaticdiseases
AT vannuccinisilvia menstruationrelateddisordersdysmenorrheaandheavybleedingassignificantepiphenomenainwomenwithrheumaticdiseases
AT elaoufykhadija menstruationrelateddisordersdysmenorrheaandheavybleedingassignificantepiphenomenainwomenwithrheumaticdiseases
AT melismariaramona menstruationrelateddisordersdysmenorrheaandheavybleedingassignificantepiphenomenainwomenwithrheumaticdiseases
AT leprigemma menstruationrelateddisordersdysmenorrheaandheavybleedingassignificantepiphenomenainwomenwithrheumaticdiseases
AT sambatarogianluca menstruationrelateddisordersdysmenorrheaandheavybleedingassignificantepiphenomenainwomenwithrheumaticdiseases
AT bellandorandonesilvia menstruationrelateddisordersdysmenorrheaandheavybleedingassignificantepiphenomenainwomenwithrheumaticdiseases
AT guiducciserena menstruationrelateddisordersdysmenorrheaandheavybleedingassignificantepiphenomenainwomenwithrheumaticdiseases
AT cerinicmarcomatucci menstruationrelateddisordersdysmenorrheaandheavybleedingassignificantepiphenomenainwomenwithrheumaticdiseases
AT petragliafelice menstruationrelateddisordersdysmenorrheaandheavybleedingassignificantepiphenomenainwomenwithrheumaticdiseases